首页 >
法规速递
-
Document: List of medicines currently in PRIME scheme-2025/6/2
2025-06-03查看详情 > -
Document: Agenda of the PRAC meeting 7-10 July 2025-2025/7/7
2025-07-08查看详情 > -
Page: Emergency Task Force (ETF)-2025/8/7
2025-08-10查看详情 > -
Document: Melatonin prolonged release tablets 2 mg product-specific bioequivalence guidance-2025/9/25
2025-09-26查看详情 > -
关于将安瑞替尼胶囊纳入“儿童抗肿瘤药物研发鼓励试点计划（星光计划）”试点项目的公示-2025/11/4
2025-11-05查看详情 > -
Document: Keeping medicines safe: Reporting side effects can make medicines safer for everyone-2025/12/3
2025-12-04查看详情 > -
Page: Aliskiren product-specific bioequivalence guidance-2026/2/10
2026-02-11查看详情 > -
国家药监局关于调整国家药监局化妆品标准化技术委员会委员的公告（2026年第30号）-2026/3/20
2026-03-23查看详情 > -
国家药监局综合司关于印发2026年化妆品标准立项计划的通知-2026/4/24
2026-04-27查看详情 > -
Document: Appendix 1: Acceptable intakes established for N-nitrosamines-2026/6/5
2026-06-08查看详情 >
